Edition:
India

Calithera Biosciences Inc (CALA.OQ)

CALA.OQ on NASDAQ Stock Exchange Global Select Market

8.75USD
2:29am IST
Change (% chg)

$-0.15 (-1.69%)
Prev Close
$8.90
Open
$9.00
Day's High
$9.05
Day's Low
$8.70
Volume
119,158
Avg. Vol
131,438
52-wk High
$20.00
52-wk Low
$3.00

Select another date:

Tue, Nov 7 2017

BRIEF-Calithera Biosciences expands clinical collaboration with Bristol-Myers Squibb

* Initial results from Phase 2 study of CB-839 in combination with opdivo® (nivolumab) to be presented at the Society for Immunotherapy of Cancer Meeting

BRIEF-Calithera Biosciences Q3 operating loss per share $0.17

* Calithera biosciences reports third quarter 2017 financial results and recent highlights

BRIEF-Calithera Biosciences files for common stock offering of up to $250 mln

* Calithera Biosciences Inc files for common stock offering of up to $250 million - SEC filing‍​ Source text: (http://bit.ly/2hHfdIt) Further company coverage:

BRIEF-Calithera Biosciences reports Q2 operating loss per share $0.15

* Calithera Biosciences reports second quarter 2017 financial results and recent highlights

BRIEF-Calithera Biosciences initiates randomized phase 2 combination trial of CB-839 in patients with renal cell carcinoma

* Calithera Biosciences initiates a randomized phase 2 combination trial of CB-839 in patients with renal cell carcinoma

Select another date: